【2026 International Symposium on Translational Research in Liver Cancer】Successfully Concluded!

2026 肝癌轉譯研究國際研討會與會人員合影 / Group photo at the 2026 International Symposium on Translational Research in Liver Cancer

The 2026 International Symposium on Translational Research in Liver Cancer has successfully concluded! The symposium brought together more than 100 clinical physicians and research professionals from across Taiwan, providing a valuable platform for academic exchange and collaboration.

We were honored to welcome Academician Jing-Hsiung James Ou from the University of Southern California and Associate Professor Daniel Q. Huang from the National University of Singapore for in-person presentations and discussions. Academician Yung-Chi Cheng from Yale University and Dr. Yee-Hui Yeo from Cleveland Clinic also joined us virtually to share their insights. Distinguished experts and scholars from Taiwan and abroad gathered to exchange ideas and share the latest research findings and emerging trends in liver cancer and liver disease.

2026 肝癌轉譯研究國際研討會學術交流 / Academic discussion at the 2026 International Symposium on Translational Research in Liver Cancer
2026 肝癌轉譯研究國際研討會演講現場 / Presentation at the 2026 International Symposium on Translational Research in Liver Cancer

We would also like to express our sincere appreciation to PHARMIGENE, Inc., Toong Yeuan Enterprise Co., Ltd., Prisma Biotech Corporation, and Roche Products Ltd. for their generous sponsorship and support. (Listed in stroke-count order of the Chinese names.)